Evidence map›Paper›PMID 36216411›Full record

ArticleThe British journal of ophthalmology2023

Prevalence and risk factors for age-related macular degeneration in a population-based cohort study of older adults in Northern Ireland using multimodal imaging: NICOLA Study.

Ruth E Hogg, David M Wright, Nicola B Quinn, Katherine Alyson Muldrew, Barbra Hamill, Laura Smyth, Amy Jayne McKnight, Jayne Woodside, Mark A Tully, Sharon Cruise and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The British journal of ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Progression to complete retinal pigment epithelium and outer retinal atrophy (cRORA): post hoc analysis of the GATHER1 trial.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Ruth E HoggCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK r.e.hogg@qub.ac.uk.ORCID 0000-0001-9413-2669
David M WrightCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK.ORCID 0000-0001-8948-3691
Nicola B QuinnCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK.
Katherine Alyson MuldrewCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK.
Barbra HamillCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK.
Laura SmythCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK.
Amy Jayne McKnightCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK.
Jayne WoodsideCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK.
Mark A TullyUlster University, Newtownabbey, UK.
Sharon CruiseCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK.
Bernadette McGuinnessBelfast Faculty of Engineering and Physical Sciences, Queen's University, Belfast, UK.
Ian S YoungCentre for Public Health, Queen's University Belfast Faculty of Arts Humanities and Social Sciences, Belfast, UK.
Frank KeeCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK.
Tunde PetoCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK.ORCID 0000-0001-6265-0381
Usha ChakravarthyCentre for Public Health, Queen's University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UK.ORCID 0000-0002-2606-3734
Queen's University Belfast · GBUniversity of Ulster · GB

Funding

Medical Research Council MC_PC_20026Wellcome Trust
6 · The paper itself

Abstract

purposeTo report prevalence and risk factor associations for age-related macular degeneration (AMD) and AMD features from multimodal retinal grading in a multidisciplinary longitudinal population-based study of aging in Northern Ireland. STUDY

designPopulation-based longitudinal cohort study.

methodsRetinal imaging at the Norther Ireland Cohort for the Longitudinal Aging Study health assessment included stereo Colour Fundus Photography (CFP) (Canon CX-1, Tokyo, Japan) and Spectral-Domain Optical Coherence Tomography (SD-OCT) ((Heidelberg Retinal Angopgraph (HRA)+OCT; Heidelberg Engineering, Heidelberg, Germany). Medical history and demographic information was obtained during a home interview. Descriptive statistics were used to describe the prevalence of AMD and individual AMD features. Multiple imputation followed by multiple regression modelling was used to explore risk factor associations including relationships with AMD genetic risk score.

resultsRetinal images from 3386 participants were available for analysis. Mean age of the sample was 63.4 (SD 9.01, range: 36-99). Population weighted prevalence of AMD using colour grading in those over 55 years was: no drusen: 6 0.4%; drusen <63 μm: 15.9%; drusen 63-125 µm: 13.7%; drusen >125 µm or pigmentary changes: 8.3%; late AMD: 1.6%. Prevalence of AMD features in those over 55 years was: OCT drusen 27.5%, complete outer retinal pigment epithelium and outer retinal atrophy (cRORA) on OCT was 4.3%, reticular drusen 3.2% and subretinal drusenoid deposits 25.7%. The genetic risk score was significantly associated with drusen and cRORA but less so for SDD alone and non-significant for hyperpigmentation or vitelliform lesions.

conclusionsMultimodal imaging-based classification has provided evidence of some divergence of genetic risk associations between classical drusen and SDD. Our findings support an urgent review of current AMD severity classification systems.

Indexed as

Macular DegenerationRetinal DrusenAgedCohort StudiesFluorescein AngiographyHumansLongitudinal StudiesNorthern IrelandPrevalenceRisk FactorsTomography, Optical Coherenceepidemiologygeneticsimagingmacularetina

Identifiers

PMID36216411
PMCPMC10715512
OpenAlexW4304098238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.